Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults

• Main Authors: Joon Young Song (Author), Jacob Lee (Author), Heung Jeong Woo (Author), Seong-Heon Wie (Author), Jin Soo Lee (Author), Shin Woo Kim (Author), Tae Hyong Kim (Author), Sook-In Jung (Author), Ji Yun Noh (Author), Won Suk Choi (Author), Hee Jin Cheong (Author), Woo Joo Kim (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Two antigenically distinct influenza B lineage viruses (Yamagata/Victoria) have been co-circulating globally since the mid-1980s. The quadrivalent influenza vaccine (QIV) may provide better protection against unpredictable B strains. We conducted a randomized, double-blind, phase III trial to evalua...